https://www.selleckchem.com/products/sbe-b-cd.html
We developed a new confirmation methodology to enhance the specificity of the assays with an anticipated specificity of 98% for IgA. Valuation of hospitalized COVID-19 patients determined median IgA seroconversion to be 8days and IgG 10days. Neither level nor timing of antibody response correlated with days on ventilation. End titer measurements indicate that validated improved assays may be capable of semi-quantitative measurement. We found these assays to be clinically acceptable for the high prevalence population tested, for instanc
Like
Comment
Share
